Conjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
- 11 September 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 19 (1), 39-49
- https://doi.org/10.1021/bc070031k
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Organic Cation Transporters Are Determinants of Oxaliplatin CytotoxicityCancer Research, 2006
- Cellular processing of platinum anticancer drugsNature Reviews Drug Discovery, 2005
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Integrins: Bidirectional, Allosteric Signaling MachinesCell, 2002
- Specialization of tumour vasculatureNature Reviews Cancer, 2002
- Kinetics and mechanism for reduction of oral anticancer platinum(IV) dicarboxylate compounds by L-ascorbate ions †J. Chem. Soc., Dalton Trans., 2000
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Requirement of Vascular Integrin α v β 3 for AngiogenesisScience, 1994
- Disruption of epithelial cell-matrix interactions induces apoptosisThe Journal of cell biology, 1994
- Arg‐Gly‐Asp constrained within cyclic pentapoptides Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1FEBS Letters, 1991